APA (7th ed.) Citation

Hoberger, M., Zuber, R. L., Burkhard-Meier, A., Di Gioia, D., Jurinovic, V., Völkl, M., . . . Berclaz, L. M. (2026). Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: A machine learning analysis. Journal of Cancer Research & Clinical Oncology, 152(1), 1. https://doi.org/10.1007/s00432-025-06410-8

Chicago Style (17th ed.) Citation

Hoberger, Michael, et al. "Long-term Benefit from High-dose Ifosfamide in Sarcoma Depends on Sustained Prior Control and Timely Intervention: A Machine Learning Analysis." Journal of Cancer Research & Clinical Oncology 152, no. 1 (2026): 1. https://doi.org/10.1007/s00432-025-06410-8.

MLA (9th ed.) Citation

Hoberger, Michael, et al. "Long-term Benefit from High-dose Ifosfamide in Sarcoma Depends on Sustained Prior Control and Timely Intervention: A Machine Learning Analysis." Journal of Cancer Research & Clinical Oncology, vol. 152, no. 1, 2026, p. 1, https://doi.org/10.1007/s00432-025-06410-8.